PLSMHealthcare · Medical Devices

PLSM Stock Forecast: Pulsenmore Ltd. Price Predictions for 2026-2027

Last close, 11 Sept 2026

$2.42

−1.22% on the day

Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 34 of 100 as at 12 Sept 2026 — in the lower half.

Market cap

$15.7M

Ticker Nerd rank

34 / 100

Median analyst target

—

Analysts covering

—

Total return, dividends reinvested

−3.2%

−25.1%

From high

−67.1%

From low

0.0%

$2.42

$7.36

Range since 21 Jan 2026, adjusted closes · the dot is the last close

Ticker Nerd rank

PLSM stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores Pulsenmore Ltd. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 12 Sept 2026

34 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Growth

Size

Value

Quality

Accruals

Revisions

Issuance

Momentum

Volatility

Growth (99): Sales and profits are climbing, and climbing faster than before.

Volatility (1): The share price moves around a lot.

Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.

Wall Street

PLSM stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on PLSM, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, since 21 Jan 2026Adjusted close, US dollars

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Data provided by Twelve Data

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. PLSM appears on the weeks it earns a place.

Performance

PLSM vs the S&P 500

Both lines are total return — dividends reinvested — so the comparison is honest on both sides.

PLSM vs S&P 500, last 12 monthsTotal return, rebased to 100

Download this chart as an image — free to reuse; link this page as the source.

Data provided by Twelve Data

Estimates

PLSM analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Fundamentals

Pulsenmore Ltd. (PLSM) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation

Trailing P/E: −1.0×
Price / sales: 0.4×
Price / book: —
EV / EBITDA: 0.6×

Growth & margins

Revenue growth (YoY): 52.0%
Earnings growth (YoY): —
Gross margin: —
Operating margin: −38.8%
Net margin: −65.9%

Returns & dividend

Return on equity: −45.2%
Return on assets: −7.0%
Dividend yield: —

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Key statistics

Pulsenmore Ltd. (PLSM) statistics: revenue, profit & scale

The headline figures, each with its date. Every row carries its own link — cite it straight from here.

Pulsenmore Ltd. has a market value of $15.7M and an enterprise value of −$4.3M.
Shares outstanding: 6.5M.
Trailing P/E: −1.0×.
Pulsenmore Ltd. employs 71 people.

market figures as at 13 Sept 2026

Data provided by Twelve Data

Peers

PLSM vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelMedical Devices

Company	Market cap	TKN rank
PLSMPulsenmore Ltd.	$15.7M	34
NMTCNeuroOne Medical Technologies Corp.	$14.2M	39
LFWDLifeward Ltd.	$20.0M	22
CTSOCytoSorbents Corp.	$20.2M	47
HSCSHeartSciences, Inc.	$13.2M	31
MODDModular Medical, Inc.	$20.7M	11
PMIPicard Medical, Inc.	$12.5M	25

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own Pulsenmore Ltd. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest PLSM news & analysis

Pulsenmore Expands into Fertility Care: Completes CE European Registration of Home Ultrasound System for Follicular Monitoring

PRNewsWire · 8 Sept 2026positive

Pulsenmore Ltd. announced that its home ultrasound system for follicular monitoring (the Pulsenmore FC system), designed for women undergoing IVF and fertility preservation treatments, has completed CE European registration. This marks the company's second product authorized in Europe and its first expansion beyond prenatal care into the broader women's health market.

Why it matters — For Pulsenmore watchers, this registration signals a strategic expansion into fertility care and the broader women's health market, broadening the company's product portfolio and European footprint beyond its prenatal care offering.

Pulsenmore Ltd. Announces Financial Results and Business Highlights for the First Half of 2026

PRNewsWire · 31 Aug 2026neutral

Pulsenmore Ltd. announced its financial results and business highlights for the six-month period ended June 30, 2026. The company presented key operational, commercial, regulatory, and technological achievements along with financial updates, and management hosted a webcast to discuss the results and provide a business update.

Why it matters — This announcement provides PLSM watchers with the company's latest financial performance and operational progress across its remote maternal-fetal healthcare and home ultrasound business.

Pulsenmore Ltd. To Announce Financial Results and Business Highlights and Hold Conference Call for the First Half of 2026

PRNewsWire · 24 Aug 2026neutral

Pulsenmore Ltd. announced it will release its financial results and business highlights for the six months ended June 30, 2026 on August 31, 2026 at 8:30 am ET, and will hold a conference call to discuss them. The company, which focuses on remote maternal-fetal healthcare and home ultrasound solutions, issued the announcement from Omer, Israel.

Why it matters — Investors tracking Pulsenmore will be able to review the company's first-half 2026 financial and operational performance when the results and accompanying conference call take place on August 31.

Pulsenmore Expands Its Home Ultrasound Activity in Israel: Ichilov Adopts the Technology, Expanding Access to At-Home Pregnancy Monitoring

PRNewsWire · 19 Aug 2026positive

Pulsenmore announced the expansion of its home ultrasound activity in Israel, with its technology being integrated at the Lis Maternity and Women's Hospital at Ichilov, joining other medical centers that already use it in pregnancy monitoring pathways.

Why it matters — This expands adoption of Pulsenmore's home ultrasound technology at another major Israeli medical center, broadening its footprint in pregnancy monitoring.

Pulsenmore Receives Second AI Grant Within One Month: Israel Innovation Authority Approves $1.27 Million for SmartScan AI Program

PRNewsWire · 17 Aug 2026positive

Pulsenmore received a second AI grant from the Israel Innovation Authority within one month, approving $1.27 million for its SmartScan AI program. Combined with a prior grant, total AI grants approved over the past month amount to approximately $1.6 million, supporting two programs with a combined scope of about $3.12 million aimed at advancing AI-powered home ultrasound.

Why it matters — A PLSM watcher would care because the grants signal continued institutional support and funding for Pulsenmore's AI-driven home ultrasound technology development.

FAQ

Frequently asked questions about PLSM stock

How does Ticker Nerd's model rank PLSM?

As at 12 Sept 2026, Pulsenmore Ltd. ranks 34 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Growth (99 of 100).

What is the PLSM stock forecast for 2030?

No analyst covering Pulsenmore Ltd. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for PLSM are extrapolating price history, which says nothing about the business.

What does Pulsenmore Ltd. do?

Pulsenmore Ltd. is a medical device company that develops portable self-scan ultrasound solutions for remote clinical diagnosis and screening.

What is the latest news on PLSM?

The most recent item we track (PRNewsWire, 8 Sept 2026): "Pulsenmore Expands into Fertility Care: Completes CE European Registration of Home Ultrasound System for Follicular Monitoring". Pulsenmore Ltd. announced that its home ultrasound system for follicular monitoring (the Pulsenmore FC system), designed for women undergoing IVF and fertility preservation treatments, has completed CE European registration. This marks the company's second product authorized in Europe and its first expansion beyond prenatal care into the broader women's health market.

Company

About Pulsenmore Ltd.

Pulsenmore Ltd. is a medical device company that develops portable self-scan ultrasound solutions for remote clinical diagnosis and screening. Its current product lineup includes home-use ultrasound systems that connect with a patient’s smartphone, allowing users to capture images for review by healthcare professionals. The company also provides a mobile application that guides patients through the scanning process and supports online consultation, along with a clinician dashboard for remote image review and scan supervision. Pulsenmore Ltd. focuses on applications in telehealth and remote monitoring, with solutions used in maternal health and fertility care. Headquartered in Omer, Israel, Pulsenmore Ltd. serves healthcare providers and patients seeking convenient ultrasound access outside traditional clinical settings.

CEO Dr. Elazar Sonnenschein · 71 employees · Israel · https://www.pulsenmore.com